吸入性皮质类固醇/长效β2抗体选择中度至重度喘患者:对现实实践的考虑,叙述性综述
John D Blakey1,2, Lorenzo Cecchi3, Christian Domingo4
1Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, WA, Australia.
Advances in therapy
|March 10, 2026
概括
选择吸入性皮质类固醇/长效β2-激动剂 (ICS/LABA) 治疗喘需要平衡临床试验数据与现实世界的证据. 患者特异性,吸入器方便性和成本等因素影响最佳的ICS/LABA选择,以更好地治疗喘.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学 是一个学科.
- 医学上的真实世界的证据.
背景情况:
- 目前的喘维护依赖于吸入性皮质类固醇/长效β2激动剂 (ICS/LABA) 疗法,一些患者需要额外的治疗.
- 随机临床试验 (RCT) 显示出积极的结果,但由于严格的患者选择标准,这些可能无法完全转化为现实世界的有效性.
- 将RCT发现推广到日常实践中是具有挑战性的,因为药物不同,患者变化和医疗保健提供者的时间限制.
研究的目的:
- 审查影响选择ICS/LABA治疗中度至重度喘的因素.
- 通过整合RCT和现实世界的证据,指导医疗保健专业人员选择合适的ICS/LABA疗法.
- 要突出考虑不同患者和疾病因素的重要性,而不仅仅是试验数据.
主要方法:
- 文献综述综合了随机临床试验 (RCT) 和现实世界证据 (RWE) 的数据.
- 对影响ICS/LABA选择临床决策的因素分析.
- 考虑药理动力学,药理动力学,患者特异性和与坚持相关的因素.
主要成果:
- 随机试验结果与现实患者结果之间存在差异.
- 选择ICS/LABA的关键因素包括临床决策,药物特性,患者坚持,吸入器可用性,炎症状态和安全性/有效性平衡.
- 现实世界的证据和患者特定的因素对于优化治疗选择至关重要.
结论:
- 选择最佳的ICS/LABA治疗需要一个全面的方法超越RCT数据.
- 医疗保健专业人员应该整合现实世界的证据,患者的特征,以及成本和可用性等实际考虑.
- 个性化的ICS/LABA选择可以改善喘管理和患者的治疗结果.
相关概念视频
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:23Inhaled Medications
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...